Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001969408 | SCV002264766 | uncertain significance | RASopathy | 2020-12-04 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has been observed in individual(s) with clinical features of Noonan syndrome (Invitae). This variant is present in population databases (rs756406841, ExAC 0.01%). This sequence change replaces proline with alanine at codon 1168 of the SOS1 protein (p.Pro1168Ala). The proline residue is highly conserved and there is a small physicochemical difference between proline and alanine. |
Ambry Genetics | RCV002458913 | SCV002615116 | uncertain significance | Cardiovascular phenotype | 2020-02-28 | criteria provided, single submitter | clinical testing | The p.P1168A variant (also known as c.3502C>G), located in coding exon 22 of the SOS1 gene, results from a C to G substitution at nucleotide position 3502. The proline at codon 1168 is replaced by alanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV002468369 | SCV002763209 | uncertain significance | Fibromatosis, gingival, 1 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002468370 | SCV002763570 | uncertain significance | Noonan syndrome 4 | criteria provided, single submitter | clinical testing | ||
Ce |
RCV003883731 | SCV004698457 | uncertain significance | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing |